ClonOrgan logo

ClonOrgan

Pioneering the future of organ transplantation with human-compatible organs grown from gene-edited pigs through a comprehensive R&D platform since 2005.

est. 2005

VS
Spotlight Therapeutics logo

Spotlight Therapeutics

Biotechnology company that develops biologics targeted to specific cell populations in gene editing

22 employees · est. 2017 · Hayward, United States

ClonOrgan is the older company (2005 vs 2017).

Side-by-Side Comparison

ClonOrgan Spotlight Therapeutics
Founded
2005 older 2017
Headquarters
Not tracked yet Hayward, United States
Employees
Not tracked yet 22
Industry
Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Series A Series B
Total Funding
$16.97M $80.70M
Funding Rounds
2 4
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Xenotransplantation, Organ Transplantation, Gene Editing, Regenerative Medicine, Medical Technology, Research And Development, Pig Organs, Human-compatible Organs, Preclinical Testing, Biomedical Innovation Gene Editing, Biologics, In Vivo Gene Editing, Oncology, Engineered Nucleases, Targeted Cell Populations, Therapeutics Development, Preclinical Development, Protein Engineering, Immuno-Oncology, In Vivo Safety Studies, Precision Medicine, Therapeutic Platform
Website
clonorgan.com spotlighttx.com
ClonOrgan logo

About ClonOrgan

ClonOrgan is a biotechnology company that has been pioneering the future of organ transplantation since its establishment in 2005. The company's slogan, "Pioneering the future of organ transplantation with human-compatible organs grown from gene-edited pigs through a comprehensive R&D platform," enc...

Spotlight Therapeutics logo

About Spotlight Therapeutics

Spotlight Therapeutics, founded in 2017 by Alex Marson, Jacob Corn, and Patrick Hsu, is a pioneering biotechnology company with a focus on creating biologics for specific cell populations through gene editing. With its innovative slogan, "Biotechnology company that develops biologics targeted to spe...

We will tell you when either one moves

BounceWatch watches ClonOrgan and Spotlight Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at ClonOrgan and Spotlight Therapeutics — by email.

Frequently Asked Questions

ClonOrgan — Pioneering the future of organ transplantation with human-compatible organs grown from gene-edited pigs through a comprehensive R&D platform since 2005.. Spotlight Therapeutics — Biotechnology company that develops biologics targeted to specific cell populations in gene editing. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
ClonOrgan has raised $16.97M while Spotlight Therapeutics has raised $80.70M.
ClonOrgan and Spotlight Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare ClonOrgan with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at ClonOrgan on 12 Sep 2024, and Spotlight Therapeutics on 10 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes